NCT06673043Active, not recruiting
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
Anifrolumab Real-world Treatment Outcomes in Polish Patients With Systemic Lupus Erythematosus (SLE). Multicenter, Non-interventional Study
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
The Polish multicentre observational (non-interventional) study aiming to collect data on the characteristic of patients with systemic lupus erythematosus and clinical outcomes of anifrolumab administered in the scope of routine clinical practice.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 105 (actual)
- First submitted
- 30 Oct 2024
- Start date
- 28 Feb 2025
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- AstraZeneca
- Diseases
- Lupus (SLE)
- NCT number
- NCT06673043
What you commit to
- Study type: Observational
- Participants enrolled: 105
- From 28 Feb 2025 to the primary completion date, 30 Jun 2028
- 11 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Those who participated in anifrolumab clinical trial in the past, and/or those who participated/plans to participate in clinical trial on/after the date of first anifrolumab infusion through NDP.
- Cognitive incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
Who the study is looking for
- Adult (aged ≥18 years old) patients with SLE who received anifrolumab treatment in the frames of NDP in Poland.
- Patients willing to participate in the study and signed Informed Consent Form (ICF).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Bydgoszcz | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Bytom | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Gdansk | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Katowice | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Krakow | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Lodz | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Lublin | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Poznan | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Rzeszów | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Warsaw | Poland | Unknown status |
| - Coordinator of this site? Confirm its status | Wroclaw | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.